Evidence-based Guidance for the Management of Postherpetic Neuralgia in Primary Care

References

• . Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–819
   PubMed Web of Science ®Google Scholar
• . Oxman MN, Levin MJ, Johnson GR, . A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–2284
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Herpes zoster vaccination for health care professionals, http://www.cdc.gov/vaccines/vpd-vac/shingles/hcp-vaccination.htm. Accessed December 13, 2012
   Google Scholar
• . Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63(6):959–965
   PubMed Web of Science ®Google Scholar
• . Dworkin RH, O'Connor AB, Audette J, . Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85( 3 suppl):S3–S14
   PubMed Web of Science ®Google Scholar
• . Attal N, Cruccu G, Baron R, ; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88
   PubMed Web of Science ®Google Scholar
• . Moulin DE, Clark AJ, Gilron I, . Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12(1):13–21
   PubMed Web of Science ®Google Scholar
• . Brainin M, Barnes M, Baron JC, . Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces— revised recommendations 2004. Eur J Neurol. 2004;11(9):577–581
   PubMed Web of Science ®Google Scholar
• . MacPherson DW. Evidence-based medicine. Can Commun Dis Rep. 1994;20(17):145–147
   PubMedGoogle Scholar
• . Moore RA, Wiffen PJ, Deny S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;3:CD007938
   PubMed Web of Science ®Google Scholar
• . Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;3:CD007076
   PubMed Web of Science ®Google Scholar
• . Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;2:CD004846
   Google Scholar
• . Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009;4:CD007393
   PubMed Web of Science ®Google Scholar
• . Edelsberg JS, Lord C, Oster G. Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother. 2011;45(12):1483–1490
   PubMedGoogle Scholar
• . Panesar SS, Philippon MJ, Bhandari M. Principles of evidence-based medicine. Orthop Clin North Am. 2010;41(2):131–138
   PubMedGoogle Scholar
• . Backonja MM, Canafax DM, Cundy KC. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Med. 2011;12(7):1098–1108
   PubMed Web of Science ®Google Scholar
• . Sang CN, Sathyanarayana R, Sweeney M; DM-1796 Study Investigators. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain. 2013;29(4):281–288
   PubMed Web of Science ®Google Scholar
• . Irving GA, Backonja MM, Dunteman E, . NGX-4010 C117 Study Group. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med. 2011;12(1):99–109
   PubMed Web of Science ®Google Scholar
• . Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. J Pain. 2010;11(10):972–982
   PubMed Web of Science ®Google Scholar
• . Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clin J Pain. 2012;28(2):101–107
   PubMed Web of Science ®Google Scholar
• . Wallace MS, Irving G, Cowles VE. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Investig. 2010;30(11):765–776
   PubMed Web of Science ®Google Scholar
• . Irving G, Jensen M, Cramer M, . Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain. 2009;25(3): 185–192
   PubMed Web of Science ®Google Scholar
• . Kim Y. Missing data handling in chronic pain trials. J Biopharm Stat. 2011;21(2):311–325
   PubMed Web of Science ®Google Scholar
• . Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26(7):1607–1619
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 2009;25(7):1677–1687
   PubMed Web of Science ®Google Scholar
• . Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain. 2010;11(5):462–471
   PubMed Web of Science ®Google Scholar
• . Barbarisi M, Pace MC, Passavanti MB, . Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 2010;26(7):567–572
   PubMed Web of Science ®Google Scholar
• . American Academy of Neurology. 2011. Clinical Practice Guideline Process Manual. Ed. St. Paul, MN: The American Academy of Neurology
   Google Scholar
• . Gralise® (gabapentine) [Package Insert]. Menlo Park, CA: Depomed, Inc.; 2012
   Google Scholar
• . Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain. 2007;23(1):15–22
   PubMed Web of Science ®Google Scholar
• . Sharma U, Griesing T, Emir B, Young JP Jr. Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Am J Ther. 2010;17(6):577–585
   PubMed Web of Science ®Google Scholar
• . Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213–224
   PubMed Web of Science ®Google Scholar
• . American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Pain Med. 2009;10(6):1062–1083
   PubMedGoogle Scholar
• . Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–2878
   PubMed Web of Science ®Google Scholar
• . Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. Ochsner J. 2010;10(3):179–187
   PubMedGoogle Scholar
• . Hadjistavropoulos T, Herr K, Turk DC, . An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain. 2007;23( 1 suppl):S1–S43
   PubMed Web of Science ®Google Scholar
• . Tylenol® Package Insert. McNeil-PCC, Inc. 1998–2013
   Google Scholar
• . American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631
   PubMed Web of Science ®Google Scholar
• . Irving GA, Sweeney M. Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia. J Pain Res. 2012;5:203–208
   PubMedGoogle Scholar
• . van Ojik AL, Jansen PA, Brouwers JR, van Roon EN. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012;29(8):615–625
   PubMedGoogle Scholar
• . Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone—metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50(6):551–559
   PubMed Web of Science ®Google Scholar
• . Warner M, Chen LH, Makuc DM, Anderson RN, Miniflo AM. Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief. 2011;81:1–8
   PubMedGoogle Scholar
• . Barber JB, Gibson SJ. Treatment of chronic non-malignant pain in the elderly: safety considerations. Drug Saf. 2009;32(6):457–474
   PubMed Web of Science ®Google Scholar
• . Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010;27(5):417–433
   PubMed Web of Science ®Google Scholar
• . Gianni W, Ceci M, Bustacchini S, . Opioids for the treatment of chronic non-cancer pain in older people. Drugs Aging. 2009;26 ( suppl 1):63–73
   PubMed Web of Science ®Google Scholar
• . Pan A, Sun Q, Okereke OI, . Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2012;55(1):63–72
   PubMedGoogle Scholar
• . Kivimäki M, Batty GD. Antidepressant drug use and future diabetes risk. Diabetologia. 2012;55(1):10–12
   PubMedGoogle Scholar
• . Chouinard G, Beauclair L, Bélanger MC. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can J Psychiatry. 1998;43(3):305
   PubMed Web of Science ®Google Scholar
• . Pande AC, Pollack MH, Crockatt J, . Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000;20(4):467–471
   PubMed Web of Science ®Google Scholar
• . Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC. Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol. 2008;23(1):18–28
   PubMed Web of Science ®Google Scholar
• . Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study. Int Clin Psychopharmacol. 2011;26(4):213–220
   PubMed Web of Science ®Google Scholar
• . Haythornthwaite JA, Clark MR, Pappagallo M, Raja SN. Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain. 2003;106(3):453–460
   PubMed Web of Science ®Google Scholar
• . Smith KJ, Roberts MS. Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain. 2007;8(5):396–404
   PubMedGoogle Scholar
• . Scherder EJ, Plooij B. Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementia. Drugs Aging. 2012;29(9):701–706
   PubMed Web of Science ®Google Scholar